Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bristol Myers Squibb Stock Rises
Bristol Myers Squibb stock rises following FDA approval of its schizophrenia drug
CNBC's Angelica Peebles joins 'Fast Money' to report on Bristol Myers Squibb's stock rise following FDA approval of Cobenfy for treating schizophrenia in adults.
Cobenfy Approval Brings 20% Upside To Bristol Myers Squibb Stock
This is a big approval for the company, given that Cobenfy doesn’t have the classic side effects seen in other antipsychotic drugs.
Bristol-Myers Squibb: Cobenfy Approval A Major Coup For The Dealmaker (Upgrade)
Bristol-Myers Squibb's acquisition of Karuna and FDA approval of Cobenfy signal growth potential, with focus on driving revenue. Read my update on BMY stock.
Valley Public Radio
7m
A new kind of drug for schizophrenia promises fewer side effects
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
The Washington Post
1d
FDA approves a novel drug for schizophrenia, a potential ‘game changer’
The new drug, Bristol Myers
Squibb
’s Cobenfy, targets a different area of the brain than traditional antipsychotic drugs to ...
9h
on MSN
Bristol Myers Squibb Stock Rises After Schizophrenia Drug Gets FDA Approval
Key Takeaways Bristol Myers Squibb's drug to treat schizophrenia was approved for use by the Food and Drug Administration.The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
High-end brothel plea
Helene: How to help
'Harry Potter' star dies
Troops to leave some bases
Stadiums to serve as shelters
Promotes watch collection
Targeted Black residents?
World's oldest cheese found
Killer gets life sentence
50/50 ball ownership suit
Meta hit with privacy fine
Ending password-sharing
WI duplicate ballot flap
NIH finds misconduct
Producing doc on Diddy
Chinese submarine sank
NC board removes 747K
Urgent safety alert for 737s
More executives leave
Heads to US-Mexico border
Pleads not guilty
Boxes to distribute Narcan
Fed inflation gauge cools
Fake Biden robocalls fine
On Secret Service failures
ISR targets Hezbollah HQ
US charges three Iranians
Related topics
Bristol Myers
Food and Drug Administration
Cobenfy
Feedback